Patrick Crowley

Dr. Patrick Crowley


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2024 in HRB Open Research
Verified
Journal Article
Open access
PDF file
PCPatrick Crowley
Patrick Crowley
EFEvelyn Flanagan
Evelyn Flanagan
Rónán O'CaoimhRónán O'Caoimh
Rónán O'Caoimh
Background While sleep disturbance is common in advanced dementia, leading to negative outcomes, there is growing evidence that sleep disturbance begins early in prodromal dementia and may contribute to cognitive decline. Sleep is therefore an important treatment target throughout the natural history of dementia. The existing literature regarding interventions for sleep in people with cognitive impairment is beset by wide heterogeneity in the sleep measurement tools used and outcome measures reported, which limits data synthesis and impedes the development of a robust evidence base for these interventions. Aim We propose to undertake a systematic review and meta-analysis to assess the evidence base from clinical trials for both pharmacological and non-pharmacological interventions to improve sleep in people with cognitive impairment. We will also extract data regarding the sleep measurement tools and outcome measures used in these studies to underpin the development of a core outcome set for future clinical trials in the area. Methods This systematic review and meta-analysis will include randomised and non-randomised controlled clinical trials that assess interventions to improve sleep in participants with mild cognitive impairment or dementia. Medline, CINAHL, PsycINFO, and the Cochrane CENTRAL database will be searched from inception to present. A flow chart will illustrate the study selection process in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. The methodological quality and risk of bias of included studies will be assessed. Heterogeneity will be tested. A narrative synthesis will be undertaken where meta-analysis is not feasible. Conclusion This systematic review and meta-analysis will help inform clinical practice by evaluating the available evidence for interventions to improve sleep in people with mild cognitive impairment or dementia. It will also facilitate the development of a core outcome set that will improve the coherence and utility of data emerging from future clinical trials.

6 November 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
PCPatrick Crowley
Patrick Crowley
AHAlasdair L. Henry
Alasdair L. Henry
EFEvelyn Flanagan
Evelyn Flanagan
IAInga Antonsdottir
Inga Antonsdottir
ABAlison Bentley
Alison Bentley
RORónán O'CAoimh
Rónán O'CAoimh
INTRODUCTION: Sleep disturbances are common in older people with cognitive impairment, potentially contributing to negative outcomes. A core outcome set (COS) is required to reduce heterogeneity in clinical trials and promote the development of high‐quality evidence to support clinical management. METHODS: A multi‐stage mixed methods study was conducted in accordance with The Core Outcome Set Standards for Development. RESULTS: A systematic review identified 287 sleep outcomes from previous clinical trials. Qualitative interviews ensured the COS was informed by what matters most to people with cognitive impairment and their caregivers. A modified Delphi process identified nine outcomes for the COS: total sleep time, sleep onset latency, wakefulness after sleep onset, number of night‐time awakenings, sleep efficiency, and measures of sleep quality, daytime sleepiness, cognition, and mood. DISCUSSION: This COS will support researchers to produce more reliable and coherent trial data to guide the management of sleep disturbances in people with neurodegenerative cognitive impairment. Highlights: Evidence is lacking regarding the treatment of sleep disturbances in people with cognitive impairment. Heterogeneity of reported outcomes in clinical trials limits data synthesis. A qualitative analysis established what matters most to people with cognitive impairment and their caregivers when determining treatment effectiveness. A Delphi panel of experts agreed upon a core outcome set. This core outcome set will improve the reliability and comparability of data from future trials.

28 October 2024 in HRB Open Research
Verified
Journal Article
Open access
PDF file
PCPatrick Crowley
Patrick Crowley
EFEvelyn Flanagan
Evelyn Flanagan
Rónán O'CaoimhRónán O'Caoimh
Rónán O'Caoimh
Background While sleep disturbance is common in dementia, leading to negative outcomes, there is growing evidence that sleep disturbance begins early in prodromal dementia and may contribute to cognitive decline. Sleep is therefore an important treatment target throughout the natural history of dementia and there is increasing interest in sleep as a modifiable risk factor. Clinical trials of interventions to improve sleep in people with cognitive impairment are beset by wide heterogeneity in the outcome measures reported. A core outcome set (COS) is urgently required to improve the coherence and comparability of data. Aim To produce a COS for clinical trials of interventions to improve sleep in people with cognitive impairment: the Sleep in Cognitive Impairment Core Outcome Set (SCICOS). Methods The Core Outcome Set-STAndards for Development: the COS-STAD recommendations will be followed. A systematic review (Registration: CRD42024556750) will identify outcome measures used in relevant clinical trials. Qualitative interviews involving people living with cognitive impairment and their caregivers will ascertain the outcome measures important to them. Finally, a modified Delphi process, involving people living with cognitive impairment and their caregivers as well as expert clinicians and researchers, will be conducted to reach consensus regarding the final composition of the SCICOS. Conclusion Interventions to improve sleep in people with cognitive impairment may reduce distress associated with sleep disturbance and, potentially, slow progression of cognitive decline. Creating the SCICOS will facilitate development of more meaningful and coherent data to drive progress in this emerging field.

18 June 2025 in HRB Open Research
Verified
Journal Article
Open access
PDF file
PCPatrick Crowley
Patrick Crowley
EFEvelyn Flanagan
Evelyn Flanagan
AHAlasdair L. Henry
Alasdair L. Henry
Rónán O'CaoimhRónán O'Caoimh
Rónán O'Caoimh
Background Sleep disturbance is common among those with cognitive impairment, potentially contributing to negative outcomes. Furthermore, growing evidence suggests that sleep disturbance is associated with the onset and progression of cognitive decline. There is therefore increasing interest in treating sleep disturbance in people with cognitive impairment. Non-pharmacological treatments for sleep disturbance are unhindered by many of the adverse effects associated with pharmacological treatments, yet evidence supporting their use in clinical practice is often lacking. Cognitive behavioural therapy for insomnia (CBT-I) is the first-line treatment for insomnia and has demonstrated effectiveness in people with cognitive impairment in a small number of trials. Digital CBT-I (dCBT-I) overcomes many of the obstacles associated with accessing CBT-I (such as limited availability of therapists and transportation) whilst presenting others (such as internet access and digital literacy). Aim To undertake a mixed-methods analysis of the usability and acceptability of a dCBT-I intervention ( Sleepio ) among people with cognitive impairment. Methods Participants will be community-dwelling adults aged ≥50 years with cognitive decline and probable insomnia. Study partners (being caregivers, family or friends of participants) will be recruited, if available, to examine how their involvement influences usability and acceptability. Participants will be given access to Sleepio , a fully automated and personalised dCBT-I programme delivered over the course of six weekly sessions. Usability and acceptability will be assessed by a bespoke questionnaire incorporating the System Usability Scale and the Usability Metric for User Experience - Lite (UMUX-Lite). Semi-structured interviews will explore participants’ experience of using the intervention. Conclusion By examining barriers and facilitators to the usability and acceptability of Sleepio among people with cognitive impairment, this study will provide insight into the potential efficacy of the intervention in this population whilst informing the design of a future definitive clinical trial.

PCPatrick Crowley
Patrick Crowley
AHAlasdair L. Henry
Alasdair L. Henry
MOMary ODonovan
Mary ODonovan
RSRuth Sheehan
Ruth Sheehan
EFEvelyn Flanagan
Evelyn Flanagan
Rónán O'CaoimhRónán O'Caoimh
Rónán O'Caoimh
Dementia is a leading and growing cause of disability worldwide. Insomnia is highly prevalent in mild cognitive impairment (MCI) and dementia and is associated with impaired cognition, functional decline, and reduced quality of life (QoL). Although sleep disturbance represents a potentially modifiable risk factor within the trajectory of cognitive impairment, there have not been many studies conducted to examine the feasibility or preliminary efficacy of digital cognitive behavioural therapy for insomnia (dCBT-I) in this population. The aim of this pilot randomised controlled feasibility study is to evaluate the acceptability, adherence, and potential clinical effects of a multi-component dCBT-I programme (Sleepio) in adults with MCI or mild dementia and comorbid insomnia. Thirty community-dwelling adults aged ≥50 years with established MCI or mild dementia (Mini-Mental State Examination ≥18; Clinical Dementia Rating 0.5–1.0) and insomnia (Sleep Condition Indicator ≤16) will be randomised (1:1) to Sleepio or a wait-list control. Feasibility outcomes include recruitment and retention rates, intervention adherence (completion of ≥4/6 sessions), and acceptability measured using validated usability scales. Secondary outcomes include changes in sleep, mood, QoL, cognition, and function over 10 weeks. Adverse events will be monitored to assess safety. Findings will inform the design of a future definitive trial evaluating digital sleep interventions in cognitively impaired populations. Ethical approval has been granted. The trial is registered at ClinicalTrials.gov (NCT07363928).

6 May 2025 in HRB Open Research
Verified
Journal Article
Open access
PDF file
PCPatrick Crowley
Patrick Crowley
EFEvelyn Flanagan
Evelyn Flanagan
Rónán O'CaoimhRónán O'Caoimh
Rónán O'Caoimh
Background While sleep disturbance is common in dementia, leading to negative outcomes, there is growing evidence that sleep disturbance begins early in prodromal dementia and may contribute to cognitive decline. Sleep is therefore an important treatment target throughout the natural history of dementia and there is increasing interest in sleep as a modifiable risk factor. Clinical trials of interventions to improve sleep in people with cognitive impairment are beset by wide heterogeneity in the outcome measures reported. A core outcome set (COS) is urgently required to improve the coherence and comparability of data. Aim To produce a COS for clinical trials of interventions to improve sleep in people with cognitive impairment: the Sleep in Cognitive Impairment Core Outcome Set (SCICOS). Methods The Core Outcome Set-STAndards for Development: the COS-STAD recommendations will be followed. A systematic review (Registration: CRD42024556750) will identify outcome measures used in relevant clinical trials. Qualitative interviews involving people living with cognitive impairment and their caregivers will ascertain the outcome measures important to them. Finally, a modified Delphi process, involving people living with cognitive impairment and their caregivers as well as expert clinicians and researchers, will be conducted to reach consensus regarding the final composition of the SCICOS. Conclusion Interventions to improve sleep in people with cognitive impairment may reduce distress associated with sleep disturbance and, potentially, slow progression of cognitive decline. Creating the SCICOS will facilitate development of more meaningful and coherent data to drive progress in this emerging field.